Skip to main content
Clinical Trials/NCT00902694
NCT00902694
Completed
N/A

Randomized Trial Of Achieving Healthy Lifestyles In Psychiatric Rehabilitation

Johns Hopkins University1 site in 1 country291 target enrollmentApril 1, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Overweight and Obesity
Sponsor
Johns Hopkins University
Enrollment
291
Locations
1
Primary Endpoint
Change in Weight Loss in Kilograms (kg)
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

This study will determine whether a behavioral weight loss intervention including dietary counseling and exercise is effective in helping people with serious mental illnesses lose weight.

Detailed Description

The objective of this study is to perform a randomized clinical trial (ACHIEVE) to definitively test the efficacy of an innovative, practical intervention to accomplish weight loss in overweight and obese persons with SMI. This multi-site trial will enroll consumers with SMI who attend ten psychiatric rehabilitation centers in Maryland and randomize participants to the ACHIEVE intervention or control. Intervention participants will receive group and individual weight loss counseling sessions and group physical activity classes. Co-primary outcomes will be change in weight from baseline to 6 and 18 months.

Registry
clinicaltrials.gov
Start Date
April 1, 2008
End Date
September 1, 2012
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in Weight Loss in Kilograms (kg)

Time Frame: 6 and 18 months

Change is from baseline to 6 months and baseline to 18 months

Secondary Outcomes

  • Minutes Cycled During Cycle Ergometry Testing(Baseline, 6 and 18 months)
  • Change in Systolic and Diastolic Blood Pressure (mmHg)(Measured at baseline, 6 and 18 months)
  • Health Status as Measured by the SF-12(Baseline, 6 and 18 months)
  • Change in Waist Circumference in Centimeters (cm)(Measured at baseline, 6 and 18 months)
  • Change in Lipids (Total Cholesterol, LDL, HDL and Triglyceride (mg/dL)(Measured at baseline, 6 and 18 months)
  • Framingham Cardiovascular Risk Score(Measured at baseline, 6 and 18 months)
  • Depression Assessed by Center for Epidemiologic Studies Depression Scale (CES-D)(Baseline, 6 and 18 months)

Study Sites (1)

Loading locations...

Similar Trials